AEON Biopharma enters underwriting agreement for stock sale
AEON Biopharma entered into an underwriting agreement with Lake Street Capital Markets to sell 17.85 million shares of Common Stock and related warrants. This planned financing will provide immediate liquidity to support the company's business development and operational needs.
View filing at SEC.gov →